Acute Pancreatitis
154
24
27
65
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
11 trials with published results (7%)
Research Maturity
65 completed trials (42% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.9%
6 terminated out of 154 trials
91.5%
+5.0% vs benchmark
10%
16 trials in Phase 3/4
17%
11 of 65 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 65 completed trials
Clinical Trials (154)
Acute Pancreatitis and Coagulation Study
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis
CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Necrosectomy With Cryotechnology for Accelerated Removal
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics
Early Oral Carbohydrate Solution vs Clear Liquid Diet in Acute Pancreatitis
Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid
Incidence of Splanchnic Venous Thrombosis in Acute Pancreatitis and it's Correlation With Severity of Pancreatitis
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Pancreatic Antibiotic Concentration Evaluation Assessment
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
Timing of CHolecystectomy In Severe PAncreatitis
Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)
Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis
iMmune SignAtures and Clinical outComes in AP